HPV communication: Review of existing research and recommendations for patient education

Ca-A Cancer Journal for Clinicians

Volumn 54, Issue 5, 2004, Pages 248-259

  Anhang, Rebecca ^a   Goodman, Annekathryn ^b   Goldie, Sue J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACCESS TO INFORMATION; ARTICLE; AWARENESS; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; COLPOSCOPY; CONDYLOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; INFORMATION DISSEMINATION; MASS MEDIUM; MEDICAL DECISION MAKING; PAPANICOLAOU TEST; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SCREENING TEST; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS PATHOGENESIS; WART VIRUS;

EID: 7044239704     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.54.5.248     Document Type: Article

References (68)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
2. Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-308.
3. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
4. Bioscience Division, Los Alamos National Laboratory, the Regents of the University of California. HPV sequence database: PV types and hosts [database online]. Available at: http://hpv-web.lanl.gov/stdgen/virus/cgi-bin/ hpv_organisms.cgi?dbname=hpv. Accessed August 23, 2004.
5. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
6. Schiffman M, Kjaer SK. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;31: 14-19.
7. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-28.
8. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003;31:41-46.
9. American Cancer Society. Cancer facts and figures 2004. Atlanta, GA: American Cancer Society, Inc.; 2004.
10. Lawson HW, Lee NC, Thames SF, et al. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol 1998;92:745-752.
11. Chen F, Trapido EJ, Davis K. Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer 1994;73:2838-2842.
12. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132:810-819.
13. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 1996.
14. ACOG committee opinion. Recommendations on frequency of Pap test screening. Number 152-March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995;49:210-211.
15. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;31:89-96.
16. Solomon D. Role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr 2003;31:97-101.
17. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
18. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.
19. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
20. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-444.
21. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84: 1616-1623.
22. Petry U, Menton S, Menton M, et al. Inclusion of HPV-testing for routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003;88:1570-1577.
23. Schneider A, Hover H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000;9:29-34.
24. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-951.
25. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Washington, DC: U.S. Department of Health and Human Services; 2003.
26. American College of Obstetrics and Gynecology. Practice bulletin: clinical management guidelines for obstetrician-gynecologists: cervical cytology screening. Obstet Gynecol 2003;102: 417-427.
27. Wright TC Jr. , Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
28. US Food and Drug Administration. FDA approves expanded use of HPV test. 2003. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html. Accessed on June 1, 2004.
29. Smith McCune K, Mancuso V, Contant V, Jackson R. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines. Am J Obstet Gynecol 2001;185:551-556.
30. Kaiser Family Foundation National Survey of Public Knowledge of HPV, the Human Papillomavirus. Available at: http://www.kff.org/womenshealth/upload/13385_1.pdf. Accessed July 22, 2004.
31. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000;96:653-656.
32. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health 2000;25:67-78.
33. Ramirez JE, Ramos DM, Clayton L, et al. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health 1997;6:113-121.
34. Yacobi E, Tennant C, Ferrante J, et al. University students' knowledge and awareness of HPV. Prev Med 1999;28:535-541.
35. Gerhardt CA, Pong K, Kollar LM, et al. Adolescents' knowledge of human papillomavirus and cervical dysplasia. J Pediatr Adolesc Gynecol 2000;13:15-20.
36. Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002;17:706-714.
37. Mays RM, Zimet GD, Winston Y, et al. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000;21:361-374.
38. Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res 2003;18:318-328.
39. Lerman C, Miller SM, Scarborough R, et al. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991;165:658-662.
40. Campion MJ, Brown JR, McCance DJ, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988;95:175-181.
41. Basen-Engquist K, Pasket ED, Buzaglo J, et al. Cervical cancer. Cancer 2003;98:2009-2014.
42. Bell S, Porter M, Kitchener H, et al. Psychological response to cervical screening. Prev Med 1995;24:610-616.
43. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl 1996;100:27-32.
44. Duncan B, Hart G, Scalar A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001;322:195-199.
45. Clarke P, Ebel C, Catotti DN, Stewart S. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996;7:197-200.
46. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-578.
47. Reed BD, Ruffin MT, Gorenflo DW, Zazove P. The psychosexual impact of human papillomavirus cervical infections. J Fam Pract 1999;48:110-116.
48. Gilbert LK, Alexander L, Grosshans JF, Jolley L. Answering frequently asked questions about HPV. Sex Transm Dis 2003;30:193-194.
49. Anhang R, Wright TC Jr., Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004;100:315-320.
50. McCaffery K, Forrest S, Waller J, et al. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003;88:42-46.
51. Blake DR, Weber B, Fletcher KE. Adolescent and Young Women's Misunderstanding of the Term "Pap Smear". Paper presented at: Annual Meeting of the Society for Adolescent Medicine; March 19-22, 2003; Seattle, WA.
52. Marteau TM, Senior V, Sasieni P. Women's understanding of a "normal smear test result": experimental questionnaire based study. BMJ 2001;322:526-528.
53. Meissner HI, Potosky AL, Convissor R. How sources of health information relate to knowledge and use of cancer screening exams. J Community Health 1992;17:153-165.
54. Johnson J. Cancer-Related Information Seeking. Creskill, NJ: Hamptom Press, Inc.; 1997.
55. James C, James N, Davies D, et al. Preferences for different sources of information about cancer. Patient Educ Couns. 1999;37:273-282.
56. Anhang R, Stryker JE, Wright TC Jr., Goldie SJ. News media coverage of human papillomavirus. Cancer 2004;100:308-314.
57. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29:725-735.
58. Digene Corporation. Available at: www.thehpvtest.com. Accessed July 22, 2004.
59. Laurance J. Extra test "could cut cervical cancers by 40%". The Independent. February 21, 2001:9.
60. Digene Corporation. Survey results show women expect more information, coverage from healthcare industry. 2002, Digene Corporation. Available at: http://www.digene.com. Accessed July 22, 2004.
61. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making Health Care Decisions: A Report on the Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. Washington, DC: US Government Printing Office; 1982.
62. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004;140:54-59.
63. Braddock CH 3rd, Fihn SD, Levinson W, et al. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting. J Gen Intern Med 1997;12:339-345.
64. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-661.
65. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-692.
66. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA 2004;291:2359-2366.
67. Monk BJ, Wiley DJ. Human papillomavirus infections: truth or consequences. Cancer 2004; 100:225-227.
68. Davis TC, Williams MV, Marin E, et al. Health literacy and cancer communication. CA Cancer J Clin 2002;52:134-149.